Nautilus, Inc. Reports Fiscal Second Quarter Results
Nautilus reported a 20% increase in net sales for the first half of fiscal 2022 compared to the previous year, totaling $322.6 million. However, net sales declined 11.2% in Q2 compared to last year, largely due to shipping constraints. The gross profit margin decreased to 30.2%, down from 42.8% in the prior year. The company has acquired VAY AG, enhancing its JRNY® platform, now boasting around 200,000 members. Despite challenges, Nautilus is investing heavily in JRNY® to achieve a 15% operating margin target by fiscal 2025.
- 20% increase in net sales for the first half fiscal 2022.
- Acquisition of VAY AG enhances JRNY® platform.
- Approximately 200,000 JRNY® members, tripling year-over-year.
- Investment in JRNY® expected to accelerate digital subscription growth.
- 11.2% decline in Q2 net sales versus last year.
- Gross profit margin decreased to 30.2%, down from 42.8% last year.
- Operating loss of $2.0 million in Q2, versus income of $44.0 million last year.
- Continued supply chain issues affecting shipping and sales.
First Half Fiscal Year 2022 Net Sales up
Advances JRNY® platform with Completed Acquisition of
JRNY® Total Members Approximately 200,000
Increasing JRNY® Investment to Accelerate Roadmap to Achieving Long-Term Operating Margin Targets
Management Comments
“Our second quarter results reflect the continued momentum of our North Star Strategy, as we capitalize on the sustained expansion of the home fitness addressable market. Second quarter fiscal 2022 net sales were up
Total Company Results
Fiscal 2022 Second Quarter Ended
-
Net sales were
, compared to$138.0 million , a decline of$155.4 million 11.2% versus last year, or down5.4% excluding sales related to the Octane brand, which was sold inOctober 2020 . Net sales are up160% , or a61% CAGR, when compared to the same period in 2019, excluding Octane. The sales decline was driven primarily by lower Direct sales and shipping constraints. Due to the severe shortage of shipping containers, some factory fulfilled orders, representing over in revenue, did not ship as planned in late September.$22 million 56% of those orders shipped in October.
-
Gross profit was
, compared to$42.1 million last year. Gross profit margins were$67.9 million 30.5% compared to43.7% last year. The 13.2 ppt decrease in gross margins was primarily due to: logistics (-8 ppts), commodities, components, and foreign exchange (-4 ppts) and increased investments in JRNY® (-1 ppt).
-
Operating expenses were
, an increase of$44.0 million , or$20.1 million 83.8% , compared to last year, primarily due to last year’s Octane Gain on$8.3 million Disposal Group , a legal settlement of ,$4.7 million more in advertising,$4.0 million increase in JRNY® investments, and acquisition expenses of$3.5 million . Total advertising expenses were$0.8 million versus$12.1 million last year, trending more towards historical levels.$8.0 million
-
Operating loss was
or negative$2.0 million 1.4% operating margin, compared to operating income of last year, primarily due to lower gross profits and higher operating expenses.$44.0 million
-
Loss from continuing operations was
, or -$4.6 million per diluted share, compared to income of$0.15 , or$34.0 million per diluted share, last year.$1.05
-
Net loss was
, or -$4.6 million per diluted share, compared to a net income of$0.15 , or$33.8 million per diluted share, last year.$1.04
-
The effective tax rate was negative
96.4% this year compared to21.7% last year, primarily due to the impact of the VAY acquisition.
-
The following statements exclude the impact of the legal settlement and acquisition costs for the three-months ended
September 30, 2021 and gain on disposal group for the same period in 20201.-
Adjusted operating expenses were
, or$38.5 million 27.9% of sales, compared to , or$32.3 million 20.8% of sales, last year. The increase was driven by increased advertising and JRNY® investments.
-
Adjusted operating income decreased to
compared to last year’s$3.5 million , driven by lower gross profit and higher adjusted operating expenses.$35.7 million
-
Adjusted income from continuing operations was
, or$0.9 million per diluted share, compared to$0.03 , or$28.0 million per diluted share.$0.87
-
Adjusted EBITDA from continuing operations was
compared to$7.1 million last year.$38.2 million
-
Adjusted operating expenses were
1 See “Reconciliation of Non-GAAP Financial Measures” and “Gain or loss on Disposal Group” for more information
Six-Months Ended
-
Net sales were
up$322.6 million 19.7% compared to last year. Excluding sales related to the Octane brand, net sales were up$269.6 million 28.2% compared to last year and up215% or a77% CAGR when compared to six-months endingSeptember 30, 2019 . The sales increase was driven primarily by robust sales of our popular SelectTech® weights.
-
Gross profit was
compared to$97.6 million last year. Gross profit margins were$115.3 million 30.2% compared to42.8% last year. The 12.6 ppts decrease in gross margins was primarily due to: logistics (-7 ppts), commodities, components, and foreign exchange (-5 ppts) and increased investments in JRNY® (-1 ppt).
-
Operating expenses were
, an increase of$81.6 million , or$3.2 million 4.1% , compared to last year, primarily due to$78.4 million more in advertising, increased JRNY® investments of$12.5 million , a legal settlement of$5.9 million , acquisition expenses of$4.7 million , and partially offset by last year’s$1.0 million Octane Loss on$20.7 million Disposal Group . Total advertising expenses were compared to$22.9 million last year.$10.4 million
-
Operating income was
compared to$15.9 million last year. The decrease was primarily due to lower gross profit and higher operating expenses.$36.9 million
-
Net income was
compared to$9.3 million last year.$28.7 million
-
The following statements exclude the impact of the legal settlement and acquisition costs for the six-months ended
September 30, 2021 and loss on disposal group for the same period in 20201.-
Adjusted operating expenses were
, or$75.9 million 23.5% of sales, compared to , or$57.8 million 21.4% of sales, last year. The increase was driven by of increased advertising and$12.5 million of increased JRNY® investments.$5.9 million
-
Adjusted operating income decreased to
compared to last year’s$21.6 million , driven by lower gross margins and higher operating expenses.$57.6 million
-
Adjusted income from continuing operations was
, or$15.1 million per diluted share, compared to$0.46 , or$44.9 million per diluted share.$1.40
-
Adjusted EBITDA from continuing operations was
compared to$28.3 million last year.$63.7 million
-
Adjusted operating expenses were
1 See “Reconciliation of Non-GAAP Financial Measures” and “Gain or loss on Disposal Group” for more information
JRNY® Update
The Company recently announced that the JRNY® digital fitness platform now includes a video library of instructor-led strength workouts for Bowflex® SelectTech® 552 and 1090 dumbbells, and that, for a limited time, purchasers of new JRNY®-enabled products will receive a one-year complimentary membership. This marks the latest step in making the JRNY® experience available to more consumers — whether they are using cardio or strength equipment.
The Company also recently introduced the Bowflex® Max Total® 16 cardio machine — the premier model in the popular, one-of-a-kind
The Company defines JRNY® Members as all individuals who have a JRNY® account and/or subscription, which includes Subscribers, their respective associated members and members who consume free content.
Segment Results
Fiscal 2022 Second Quarter Ended
Direct Segment
-
Direct segment sales were
, compared to$37.9 million a decline of$61.2 million 38.1% versus last year, and up134% or a53% CAGR compared to the same period in 2019. Demand trends and sales results for the quarter were more in line with pre-pandemic seasonality.
-
Cardio sales declined
49.4% versus last year and were up80% or a34% CAGR compared to the same period in 2019. Lower sales this quarter were primarily driven by lower bike sales, partially offset by increased sales of treadmills and the Max M9, which was the Direct segment’s best-selling model. Strength product sales declined8.7% versus last year and increased310% or a103% CAGR compared to the same period in 2019. Lower sales this quarter were primarily driven by lower sales of Bowflex® Home Gyms partially offset by increased sales of SelectTech® weights.
-
Given the improvement in the Company’s inventory position and the ability to fulfill orders within the quarter, the Direct segment's backlog as of
September 30, 2021 is down to compared to$1.1 million as of$26.5 million March 31, 2021 . These amounts represent unfulfilled consumer orders net of current promotional programs and sales discounts.
-
Gross profit margins were
36.9% versus57.2% last year. The 20.3 ppt decrease in gross margin was primarily driven by: logistics (-13 ppts), increased investments in JRNY® (-5 ppts) and commodities, components, and foreign exchange (-2 ppts). Gross profit was , down$14.0 million 60.1% versus last year.
-
Segment contribution loss was
or$1.8 million 4.8% of sales, compared to or$17.6 million 28.7% of sales last year. The decline was primarily driven by lower gross profit, including increased investments in JRNY®, partially offset by decreased media spend. Advertising expenses were compared to$6.8 million last year.$8.0 million
Retail Segment
-
Retail segment sales were
, up by$99.2 million 6.4% versus last year. Excluding sales related to Octane, net sales were up18.6% compared to last year and up175% or a66% CAGR compared to the same period in 2019. Retail segment sales outsidethe United States andCanada were57% excluding Octane and up655% or a175% CAGR compared to the same period in 2019.
-
Cardio sales declined by
18.2% versus last year. Excluding sales of the Octane brand, cardio sales were down5.6% compared to last year, or up120% or a48% CAGR compared to the same period in 2019. Lower sales this quarter were primarily driven by bikes and ellipticals. Strength product sales grew by89.8% versus last year, or up333% or a108% CAGR compared to the same period in 2019, led by the popular SelectTech® weights.
-
As of
September 30, 2021 , the Retail segment's backlog totaled compared to$82.9 million as of$178.6 million March 31, 2021 . These amounts represent customer orders for future shipments and are net of contractual rebates and consideration payable to applicable Retail customers. Due to the severe shortage of shipping containers, some factory fulfilled orders, representing over of the Retail backlog, did not ship as planned in late September.$22 million 56% of those orders shipped in October.
-
Gross profit margins were
27.4% compared to34.3% last year. The 6.9 ppt decrease in gross margin was primarily driven by: commodities, components, and foreign exchange (-4 ppts) and logistics (-3 ppts). Gross profit was , a decrease of$27.1 million 15% versus last year.
-
Segment contribution income was
, or$18.7 million 18.9% of sales, compared to , or$23.4 million 25.2% of sales, last year. The decline was primarily driven by lower gross profit.
Comparison of Segment Results for the Six-Month Period Ended
Direct Segment
-
Net sales for the six-month period ended
September 30, 2021 or First Half were , down$101.2 million 9.3% versus last year or up173% or a65% CAGR compared to the same period in 2019. Decreased sales this year were driven primarily by cardio products which declined by40.1% versus last year, due to lower sales of bikes and partially offset by increased sales of treadmills and max trainers. Strength product sales grew117.9% versus last year, driven by SelectTech® weights and benches.
-
Gross profit margin for the six-month period ended
September 30, 2021 were38.0% down from56.0% last year. The 18.0 ppt decrease in gross profit margin was primarily driven by: logistics (-12 ppts), commodities, components, and foreign exchange (-3 ppts) and increased investments in JRNY® (-3 ppts). Gross profit was , a decrease of$38.5 million 38.4% versus last year.
Retail Segment
-
Net sales for the six-month period ended
September 30, 2021 or First Half were , up$219.6 million 40.7% versus last year. Excluding sales related to Octane, net sales were up58.9% versus last year, and up243% , or an85% CAGR compared to the same period in 2019. Cardio sales were up23.0% versus last year, driven primarily by bikes and treadmills. Excluding sales related to Octane, cardio sales were up44.4% versus last year, and up243% or an85% CAGR compared to the same period in 2019. Strength sales were up101.5% versus last year, driven primarily by SelectTech® weights and up242% or an85% CAGR compared to the same period in 2019.
-
Gross profit margins for the six-month period ended
September 30, 2021 were26.1% , down from32.7% last year. The 6.6 ppt decrease in gross profit margin was primarily driven by: commodities, components, and foreign exchange (-4 ppts) and logistics (-3 ppts). Gross profit was , an increase of$57.4 million 12.6% versus last year.
Balance Sheet and Other Key Highlights as of
-
Cash and Liquidity:
-
Cash, cash equivalents, and restricted cash were
, compared to cash, cash equivalents, restricted cash and available-for-sale securities of$21.5 million as of$113.2 million March 31, 2021 . The decrease was primarily due to the strategic decision to increase on-hand inventory for the holiday season and the acquisition of VAY.
-
Debt and other borrowings were
compared to$17.2 million as of$13.3 million March 31, 2021 .
-
was available for borrowing under the Wells Fargo Asset Based Lending Revolving Facility (“Facility”) compared to$49.0 million as of$54.4 million March 31, 2021 .
-
On
October 29, 2021 we amended our Facility to increase our revolver size from to$55.0 million and extended the maturity date to$100.0 million October 29, 2026 .
-
Cash, cash equivalents, and restricted cash were
-
Inventory was
, compared to$162.7 million as of$68.1 million March 31, 2021 . The increase in inventory is driven by the strategic decision to increase on-hand inventory levels ahead of the fitness season given continued disruption in global logistics. About40% of inventory as ofSeptember 30, 2021 was in-transit.
-
Trade receivables were
as of$88.7 million September 30, 2021 andMarch 31, 2021 . Trade receivables were flat due to the timing of customer payments on decreased sales.
-
Trade payables were
, compared to$115.2 million as of$98.9 million March 31, 2021 . The increase in trade payables was primarily due to the timing of payments for inventory.
-
Capital expenditures totaled
for the six-months ended$5.0 million September 30, 2021 .
Forward Looking Guidance
Back Half of Fiscal 2022
- The Company’s revenue for the next few quarters will be compared to record results due to the pandemic’s effect on net sales last year. To gauge continued progress against the expanded addressable market, the Company will be measuring business versus the same period two years ago for the next few quarters.
-
The Company expects total company net sales for the back half of fiscal 2022 to be between
and$290 million , a 2-year revenue CAGR of$320 million 21% to27% . Sales guidance reflects to$6.0 million of deferred revenue related to the Company’s plan to continue bundling 12-month JRNY® trials with cardio equipment sales.$7.0 million
- The Company expects global supply chain challenges to continue pressuring gross margins in the back half. Gross margins are expected to be 15 to 17 percentage points lower than the same period last year driven by increased logistics, deferred revenue, and investments in JRNY®.
- The Company was pleased with the results of the JRNY® investments in the 1st Half and plans to increase investments in the back half to accelerate membership acquisition. The Company expects these investments to dilute operating margins by 5 to 6 percentage points.
- The Company expects to increase advertising spend in the 2nd Half by 9 to 11 percentage points as a rate of sales to market the latest connected fitness offerings to remain competitive in share of voice in the upcoming fitness season.
- Lastly, the Company expects to continue investing in the infrastructure needed to scale and expects these investments to dilute operating margins by 4 to 5 percentage points.
- Given these investments and the external macro pressure on gross margin, the Company expects a loss in the back half with negative operating margins in the mid-teens.
-
The Company continues to expect full year capital expenditures to be between
and$12 million with the majority earmarked for JRNY® investments.$14 million
- The Company is raising their guidance for JRNY® members to 250,000 to 350,000 by the end of FY22.
Longer term view, beyond Fiscal 2022
-
For fiscal year 2023, the Company expects gross margin to improve to the low
30% range driven by stabilization in the logistics environment and the accretive impact of the higher margin subscription business. Thus, the Company expects to return to positive adjusted EBITDA in fiscal year 2023.
-
The Company stated that they have made the strategic decision to accelerate investments in JRNY for the remainder of fiscal 2022 and through fiscal 2023 with a focus on product innovation and marketing. The Company now believes that JRNY will be accretive sooner than previously expected and will accelerate the achievement of their long-term operating margin goal of
15% by one year to FYE 2025, with margins expanding to high teens by FYE 26.
Conference Call
Nautilus will discuss our fiscal 2022 second quarter ended
A telephonic playback will be available from
About
Headquartered in
Forward-Looking Statements
This press release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including: projected, targeted or forecasted financial, operating results and capital expenditures, including but not limited to net sales growth rates, gross margins, operating expenses, operating margins, anticipated demand for the Company's new and existing products, statements regarding the Company's prospects, resources or capabilities; planned investments, strategic initiatives and the anticipated or targeted results of such initiatives; the effects of the COVID-19 pandemic on the Company’s business; and planned operational initiatives and the anticipated cost-saving results of such initiatives. All of these forward-looking statements are subject to risks and uncertainties that may change at any time. Factors that could cause Nautilus, Inc.’s actual expectations to differ materially from these forward-looking statements also include: weaker than expected demand for new or existing products; our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs; risks associated with current and potential delays, work stoppages, or supply chain disruptions, including shipping delays due to the severe shortage of shipping containers; an inability to pass along or otherwise mitigate the impact of raw material price increases and other cost pressures, including unfavorable currency exchange rates and increased shipping costs; experiencing delays and/or greater than anticipated costs in connection with launch of new products, entry into new markets, or strategic initiatives; our ability to hire and retain key management personnel; changes in consumer fitness trends; changes in the media consumption habits of our target consumers or the effectiveness of our media advertising; a decline in consumer spending due to unfavorable economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crises; softness in the retail marketplace; availability and timing of capital for financing our strategic initiatives, including being able to raise capital on favorable terms or at all; changes in the financial markets, including changes in credit markets and interest rates that affect our ability to access those markets on favorable terms and the impact of any future impairment. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the
RESULTS OF OPERATIONS INFORMATION
The following summary contains information from our consolidated statements of operations for the three and six-months ended
|
Three-Months Ended |
|
Six-Months Ended |
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
Net sales |
$ |
137,959 |
|
|
$ |
155,391 |
|
|
$ |
322,552 |
|
|
$ |
269,579 |
|
|
Cost of sales |
95,906 |
|
|
87,453 |
|
|
224,994 |
|
|
154,245 |
|
|||||
Gross profit |
42,053 |
|
|
67,938 |
|
|
97,558 |
|
|
115,334 |
|
|||||
Operating expenses: |
|
|
|
|
|
|
|
|||||||||
Selling and marketing |
21,939 |
|
|
19,207 |
|
|
43,239 |
|
|
31,653 |
|
|||||
General and administrative |
16,376 |
|
|
8,841 |
|
|
27,899 |
|
|
18,156 |
|
|||||
Research and development |
5,688 |
|
|
4,240 |
|
|
10,503 |
|
|
7,968 |
|
|||||
(Gain) loss on disposal group |
— |
|
|
(8,345 |
) |
|
— |
|
|
20,668 |
|
|||||
Total operating expenses |
44,003 |
|
|
23,943 |
|
|
81,641 |
|
|
78,445 |
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Operating (loss) income |
(1,950 |
) |
|
43,995 |
|
|
15,917 |
|
|
36,889 |
|
|||||
Other expense, net |
(375 |
) |
|
(628 |
) |
|
(788 |
) |
|
(850 |
) |
|||||
(Loss) income from continuing operations before income taxes |
(2,325 |
) |
|
43,367 |
|
|
15,129 |
|
|
36,039 |
|
|||||
Income tax expense |
2,242 |
|
|
9,398 |
|
|
5,680 |
|
|
7,056 |
|
|||||
(Loss) income from continuing operations |
(4,567 |
) |
|
33,969 |
|
|
9,449 |
|
|
28,983 |
|
|||||
Loss from discontinued operations, net of income taxes |
(35 |
) |
|
(131 |
) |
|
(167 |
) |
|
(255 |
) |
|||||
Net (loss) income |
$ |
(4,602 |
) |
|
$ |
33,838 |
|
|
$ |
9,282 |
|
|
$ |
28,728 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Basic (loss) income per share from continuing operations |
$ |
(0.15 |
) |
|
$ |
1.13 |
|
|
$ |
0.31 |
|
|
$ |
0.97 |
|
|
Basic loss per share from discontinued operations |
— |
|
|
— |
|
|
(0.01 |
) |
|
(0.01 |
) |
|||||
Basic net (loss) income per share |
$ |
(0.15 |
) |
|
$ |
1.13 |
|
|
$ |
0.30 |
|
|
$ |
0.96 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Diluted (loss) income per share from continuing operations |
$ |
(0.15 |
) |
|
$ |
1.05 |
|
|
$ |
0.29 |
|
|
$ |
0.90 |
|
|
Diluted loss per share from discontinued operations |
— |
|
|
(0.01 |
) |
|
— |
|
|
— |
|
|||||
Diluted net (loss) income per share |
$ |
(0.15 |
) |
|
$ |
1.04 |
|
|
$ |
0.29 |
|
|
$ |
0.90 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Shares used in per share calculations: |
|
|
|
|
|
|
|
|||||||||
Basic |
30,968 |
|
|
30,038 |
|
|
30,833 |
|
|
29,974 |
|
|||||
Diluted |
30,968 |
|
|
32,401 |
|
|
32,437 |
|
|
32,038 |
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Select Metrics: |
|
|
|
|
|
|
|
|||||||||
Gross margin |
30.5 |
% |
|
43.7 |
% |
|
30.2 |
% |
|
42.8 |
% |
|||||
Selling and marketing % of net sales |
15.9 |
% |
|
12.4 |
% |
|
13.4 |
% |
|
11.7 |
% |
|||||
General and administrative % of net sales |
11.9 |
% |
|
5.7 |
% |
|
8.6 |
% |
|
6.7 |
% |
|||||
Research and development % of net sales |
4.1 |
% |
|
2.7 |
% |
|
3.3 |
% |
|
3.0 |
% |
|||||
Operating (loss) income % of net sales |
(1.4 |
)% |
|
28.3 |
% |
|
4.9 |
% |
|
13.7 |
% |
|||||
SEGMENT INFORMATION
following tables present certain comparative information by segment and major product lines within each business segment for the three and six-months ended
|
Three-Months Ended |
|
Change |
||||||||||||
|
2021 |
|
2020 |
|
$ |
% |
|||||||||
Net sales: |
|
|
|
|
|
|
|||||||||
Direct net sales: |
|
|
|
|
|
|
|||||||||
Cardio products(1) |
$ |
22,406 |
|
|
$ |
44,278 |
|
|
$ |
(21,872 |
) |
(49.4 |
)% |
||
Strength products(2) |
15,447 |
|
|
16,916 |
|
|
(1,469 |
) |
(8.7 |
)% |
|||||
Direct |
37,853 |
|
|
61,194 |
|
|
(23,341 |
) |
(38.1 |
)% |
|||||
|
|
|
|
|
|
|
|||||||||
Retail net sales: |
|
|
|
|
|
|
|||||||||
Cardio products(1) |
58,848 |
|
|
71,924 |
|
|
(13,076 |
) |
(18.2 |
)% |
|||||
Strength products(2) |
40,305 |
|
|
21,231 |
|
|
19,074 |
|
89.8 |
% |
|||||
Retail |
99,153 |
|
|
93,155 |
|
|
5,998 |
|
6.4 |
% |
|||||
|
|
|
|
|
|
|
|||||||||
Royalty |
953 |
|
|
1,042 |
|
|
(89 |
) |
(8.5 |
)% |
|||||
Consolidated net sales |
$ |
137,959 |
|
|
$ |
155,391 |
|
|
$ |
(17,432 |
) |
(11.2 |
)% |
||
|
|
|
|
|
|
|
|||||||||
Gross profit: |
|
|
|
|
|
|
|||||||||
Direct |
$ |
13,976 |
|
|
$ |
34,990 |
|
|
$ |
(21,014 |
) |
(60.1 |
)% |
||
Retail |
27,124 |
|
|
31,906 |
|
|
(4,782 |
) |
(15.0 |
)% |
|||||
Royalty |
953 |
|
|
1,042 |
|
|
(89 |
) |
(8.5 |
)% |
|||||
Consolidated gross profit |
$ |
42,053 |
|
|
$ |
67,938 |
|
|
$ |
(25,885 |
) |
(38.1 |
)% |
||
|
|
|
|
|
|
|
|||||||||
Gross margin: |
|
|
|
|
|
|
|||||||||
Direct |
36.9 |
% |
|
57.2 |
% |
|
(2,030 |
) |
basis points |
||||||
Retail |
27.4 |
% |
|
34.3 |
% |
|
(690 |
) |
basis points |
||||||
|
|
|
|
|
|
|
|||||||||
Contribution: |
|
|
|
|
|
|
|||||||||
Direct |
$ |
(1,835 |
) |
|
$ |
17,588 |
|
|
$ |
(19,423 |
) |
(110.4 |
)% |
||
Retail |
18,741 |
|
|
23,442 |
|
|
(4,701 |
) |
(20.1 |
)% |
|||||
Royalty |
953 |
|
|
1,042 |
|
|
(89 |
) |
(8.5 |
)% |
|||||
Consolidated contribution |
$ |
17,859 |
|
|
$ |
42,072 |
|
|
$ |
(24,213 |
) |
(57.6 |
)% |
||
|
|
|
|
|
|
|
|||||||||
Reconciliation of consolidated contribution to (loss) income from continuing operations: |
|
||||||||||||||
Consolidated contribution |
$ |
17,859 |
|
|
$ |
42,072 |
|
|
$ |
(24,213 |
) |
(57.6 |
)% |
||
Amounts not directly related to segments: |
|
|
|
|
|
|
|||||||||
Operating expenses |
(19,809 |
) |
|
1,923 |
|
|
(21,732 |
) |
(1,130.1 |
)% |
|||||
Other expense, net |
(375 |
) |
|
(628 |
) |
|
253 |
|
40.3 |
% |
|||||
Income tax expense |
(2,242 |
) |
|
(9,398 |
) |
|
7,156 |
|
76.1 |
% |
|||||
(Loss) income from continuing operations |
$ |
(4,567 |
) |
|
$ |
33,969 |
|
|
$ |
(38,536 |
) |
(113.4 |
)% |
||
(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, Bowflex® VeloCore®, Schwinn® IC4, |
(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories. |
|
|||||||||||||||
Six-Months Ended |
|
Change |
|||||||||||||
|
2021 |
|
2020 |
|
$ |
% |
|||||||||
Net sales: |
|
|
|
|
|
|
|||||||||
Direct net sales: |
|
|
|
|
|
|
|||||||||
Cardio products(1) |
$ |
53,836 |
|
|
$ |
89,863 |
|
|
$ |
(36,027 |
) |
(40.1 |
)% |
||
Strength products(2) |
47,413 |
|
|
21,764 |
|
|
25,649 |
|
117.9 |
% |
|||||
Direct |
101,249 |
|
|
111,627 |
|
|
(10,378 |
) |
(9.3 |
)% |
|||||
|
|
|
|
|
|
|
|||||||||
Retail net sales: |
|
|
|
|
|
|
|||||||||
Cardio products(1) |
148,772 |
|
|
120,935 |
|
|
27,837 |
|
23.0 |
% |
|||||
Strength products(2) |
70,865 |
|
|
35,168 |
|
|
35,697 |
|
101.5 |
% |
|||||
Retail |
219,637 |
|
|
156,103 |
|
|
63,534 |
|
40.7 |
% |
|||||
|
|
|
|
|
|
|
|||||||||
Royalty |
1,666 |
|
|
1,849 |
|
|
(183 |
) |
(9.9 |
)% |
|||||
Consolidated net sales |
$ |
322,552 |
|
|
$ |
269,579 |
|
|
$ |
52,973 |
|
19.7 |
% |
||
|
|
|
|
|
|
|
|||||||||
Gross profit: |
|
|
|
|
|
|
|||||||||
Direct |
$ |
38,490 |
|
|
$ |
62,513 |
|
|
$ |
(24,023 |
) |
(38.4 |
)% |
||
Retail |
57,402 |
|
|
50,972 |
|
|
6,430 |
|
12.6 |
% |
|||||
Royalty |
1,666 |
|
|
1,849 |
|
|
(183 |
) |
(9.9 |
)% |
|||||
Consolidated gross profit |
$ |
97,558 |
|
|
$ |
115,334 |
|
|
$ |
(17,776 |
) |
(15.4 |
)% |
||
|
|
|
|
|
|
|
|||||||||
Gross margin: |
|
|
|
|
|
|
|||||||||
Direct |
38.0 |
% |
|
56.0 |
% |
|
(1,800 |
) |
basis points |
||||||
Retail |
26.1 |
% |
|
32.7 |
% |
|
(660 |
) |
basis points |
||||||
|
|
|
|
|
|
|
|||||||||
Contribution: |
|
|
|
|
|
|
|||||||||
Direct |
$ |
4,924 |
|
|
$ |
34,583 |
|
|
$ |
(29,659 |
) |
(85.8 |
)% |
||
Retail |
40,831 |
|
|
35,055 |
|
|
5,776 |
|
16.5 |
% |
|||||
Royalty |
1,666 |
|
|
1,849 |
|
|
(183 |
) |
(9.9 |
)% |
|||||
Consolidated contribution |
$ |
47,421 |
|
|
$ |
71,487 |
|
|
$ |
(24,066 |
) |
(33.7 |
)% |
||
|
|
|
|
|
|
|
|||||||||
Reconciliation of consolidated contribution to income from continuing operations: |
|
||||||||||||||
Consolidated contribution |
$ |
47,421 |
|
|
$ |
71,487 |
|
|
$ |
(24,066 |
) |
(33.7 |
)% |
||
Amounts not directly related to segments: |
|
|
|
|
|
|
|||||||||
Operating expenses |
(31,504 |
) |
|
(34,598 |
) |
|
3,094 |
|
8.9 |
% |
|||||
Other expense, net |
(788 |
) |
|
(850 |
) |
|
62 |
|
7.3 |
% |
|||||
Income tax expense |
(5,680 |
) |
|
(7,056 |
) |
|
1,376 |
|
19.5 |
% |
|||||
Income from continuing operations |
$ |
9,449 |
|
|
$ |
28,983 |
|
|
$ |
(19,534 |
) |
(67.4 |
)% |
||
|
|
|
|
|
|
|
(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, Bowflex® VeloCore®, Schwinn® IC4, |
(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories. |
BALANCE SHEET INFORMATION
The following summary contains information from our consolidated balance sheets as of
|
As of |
|||||||
|
|
|
|
|||||
Assets |
|
|
|
|||||
|
|
|
|
|||||
Cash and cash equivalents |
$ |
20,179 |
|
|
$ |
38,441 |
|
|
Restricted cash |
1,339 |
|
|
1,339 |
|
|||
Available-for-sale securities |
— |
|
|
73,448 |
|
|||
Trade receivables, net of allowances |
88,712 |
|
|
88,657 |
|
|||
Inventories |
162,669 |
|
|
68,085 |
|
|||
Prepaids and other current assets |
13,120 |
|
|
25,840 |
|
|||
Income taxes receivable |
2,404 |
|
|
— |
|
|||
Total current assets |
288,423 |
|
|
295,810 |
|
|||
Property, plant and equipment, net |
29,463 |
|
|
24,496 |
|
|||
Operating lease right-of-use assets |
24,540 |
|
|
19,108 |
|
|||
|
24,508 |
|
|
— |
|
|||
Other intangible assets, net |
9,334 |
|
|
9,365 |
|
|||
Deferred income tax assets, non-current |
2,950 |
|
|
2,144 |
|
|||
Income taxes receivable, non-current |
5,673 |
|
|
— |
|
|||
Other assets – restricted, non-current |
3,887 |
|
|
— |
|
|||
Other assets |
2,252 |
|
|
3,307 |
|
|||
Total assets |
$ |
391,030 |
|
|
$ |
354,230 |
|
|
|
|
|
|
|||||
Liabilities and Shareholders' Equity |
|
|
|
|||||
|
|
|
|
|||||
Trade payables |
$ |
115,238 |
|
|
$ |
98,878 |
|
|
Accrued liabilities |
22,402 |
|
|
19,627 |
|
|||
Operating lease liabilities, current portion |
4,766 |
|
|
3,384 |
|
|||
Warranty obligations, current portion |
5,899 |
|
|
7,243 |
|
|||
Income taxes payable, current portion |
595 |
|
|
5,709 |
|
|||
Debt payable, current portion, net of unamortized debt issuance costs |
3,250 |
|
|
3,000 |
|
|||
Total current liabilities |
152,150 |
|
|
137,841 |
|
|||
Operating lease liabilities, non-current |
22,006 |
|
|
17,875 |
|
|||
Warranty obligations, non-current |
1,467 |
|
|
1,408 |
|
|||
Income taxes payable, non-current |
3,990 |
|
|
3,657 |
|
|||
Other non-current liabilities |
4,908 |
|
|
607 |
|
|||
Debt payable, non-current, net of unamortized debt issuance costs |
13,998 |
|
|
10,297 |
|
|||
Shareholders' equity |
192,511 |
|
|
182,545 |
|
|||
Total liabilities and shareholders' equity |
$ |
391,030 |
|
|
$ |
354,230 |
|
|
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
Non-GAAP Presentation
In addition to disclosing its financial results determined in accordance with GAAP, Nautilus has presented in this release certain non-GAAP financial measures, which exclude the impact of certain items (as further described below) and provide supplemental information regarding operating performance. Nautilus presents non-GAAP financial measures as a complement to results provided in accordance with GAAP, and the non-GAAP financial measures should not be regarded as a substitute for GAAP. By disclosing these non-GAAP financial measures, management intends to provide investors with a supplemental comparison of operating results and trends for the periods presented. Management believes these measures are also useful to investors as such measures allow investors to evaluate performance using the same metrics that management uses to evaluate past performance and prospects for future performance. Nautilus strongly encourages you to review all its financial statements and publicly filed reports in their entirety and to not rely on any single financial measure.
EBITDA from Continuing Operations
Nautilus defines EBITDA from continuing operations as its income from continuing operations, adjusted to exclude interest expense (income), income tax expense (benefit) of continuing operations, and depreciation and amortization expense. Nautilus uses EBITDA from continuing operations in evaluating its operating results and for financial and operational decision-making purposes such as budgeting and establishing operational goals. Nautilus believes that EBITDA from continuing operations helps identify underlying trends in its business that could otherwise be masked by the effect of the items that are excluded from EBITDA from continuing operations and enhances the overall understanding of the Company’s past performance and future prospects. Management believes that EBITDA is frequently used by investors, securities analysts, and other interested parties in their evaluation of companies, many of which present EBITDA when reporting their results. Other companies may calculate EBITDA differently, and it may not be comparable.
Adjusted Results
In addition to disclosing the comparable GAAP results, Nautilus has presented its operating expenses, operating income (loss), and income (loss) from continuing operations on an adjusted basis. Adjusted operating expenses excludes the non-cash charges related to the disposal group held-for-sale of
Adjusted EBITDA from Continuing Operations
In addition to presenting its EBITDA from continuing operations as described above, Nautilus has also presented EBITDA from continuing operations on an adjusted basis, to exclude the non-cash charge related to stock-based compensation expense, legal settlements, and acquisition costs. We believe that the adjustment of this charge, which is inconsistent in amount and frequency, supplements the EBITDA information with a measure that can be used to assess the sustainability of our operating performance.
The following table presents a reconciliation of operating expenses, the most directly comparable GAAP measure, to Adjusted operating expenses for the three and six-month periods ended
|
Three-Months Ended |
|
Six-Months Ended |
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
Operating expenses |
$ |
44,003 |
|
|
$ |
23,943 |
|
|
$ |
81,641 |
|
|
$ |
78,445 |
|
|
Gain (loss) on disposal group(1) |
— |
|
|
8,345 |
|
|
— |
|
|
(20,668 |
) |
|||||
Legal settlements |
(4,665 |
) |
|
— |
|
|
(4,665 |
) |
|
— |
|
|||||
Acquisition costs |
(818 |
) |
|
— |
|
|
(1,030 |
) |
|
— |
|
|||||
Adjusted operating expenses |
$ |
38,520 |
|
|
$ |
32,288 |
|
|
$ |
75,946 |
|
|
$ |
57,777 |
|
|
The following table presents a reconciliation of operating (loss) income, the most directly comparable GAAP measure, to Adjusted operating income for the three and six-month periods ended
|
Three-Months Ended |
|
Six-Months Ended |
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
Operating (loss) income |
$ |
(1,950 |
) |
|
$ |
43,995 |
|
|
$ |
15,917 |
|
|
$ |
36,889 |
|
|
(Gain) loss on disposal group(1) |
— |
|
|
(8,345 |
) |
|
— |
|
|
20,668 |
|
|||||
Legal settlements |
4,665 |
|
|
— |
|
|
4,665 |
|
|
— |
|
|||||
Acquisition costs |
818 |
|
|
— |
|
|
1,030 |
|
|
— |
|
|||||
Adjusted operating income |
$ |
3,533 |
|
|
$ |
35,650 |
|
|
$ |
21,612 |
|
|
$ |
57,557 |
|
|
The following table presents a reconciliation of (loss) income from continuing operations, the most directly comparable GAAP measure, to Adjusted income from continuing operations for the three and six-month periods ended
|
Three-Months Ended |
|
Six-Months Ended |
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
(Loss) income from continuing operations |
$ |
(4,567 |
) |
|
$ |
33,969 |
|
|
$ |
9,449 |
|
|
$ |
28,983 |
|
|
(Gain) loss on disposal group(1) |
— |
|
|
(8,345 |
) |
|
— |
|
|
20,668 |
|
|||||
Income tax expense (benefit) for (gain) loss on disposal group |
— |
|
|
2,420 |
|
|
— |
|
|
(4,796 |
) |
|||||
Legal settlements |
4,665 |
|
|
— |
|
|
4,665 |
|
|
— |
|
|||||
Acquisition costs |
818 |
|
|
— |
|
|
1,030 |
|
|
— |
|
|||||
Adjusted income from continuing operations |
$ |
916 |
|
|
$ |
28,044 |
|
|
$ |
15,144 |
|
|
$ |
44,855 |
|
|
The following table presents a reconciliation of (loss) income from continuing operations, the most directly comparable GAAP measure, to EBITDA from continuing operations for the three and six-month periods ended
|
Three-Months Ended |
|
Six-Months Ended |
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
(Loss) income from continuing operations |
$ |
(4,567 |
) |
|
$ |
33,969 |
|
|
$ |
9,449 |
|
|
$ |
28,983 |
|
|
Interest expense, net |
469 |
|
|
252 |
|
|
762 |
|
|
589 |
|
|||||
Income tax expense from continuing operations |
2,242 |
|
|
9,398 |
|
|
5,680 |
|
|
7,056 |
|
|||||
Depreciation and amortization |
1,944 |
|
|
1,853 |
|
|
3,979 |
|
|
4,497 |
|
|||||
Earnings before interest, taxes, depreciation, and amortization (EBITDA) from continuing operations |
$ |
88 |
|
|
$ |
45,472 |
|
|
$ |
19,870 |
|
|
$ |
41,125 |
|
|
The following table presents a reconciliation of (loss) income from continuing operations, the most directly comparable GAAP measure, to Adjusted EBITDA from continuing operations for the three and six-month periods ended
|
Three-Months Ended |
|
Six-Months Ended |
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
(Loss) income from continuing operations |
$ |
(4,567 |
) |
|
$ |
33,969 |
|
|
$ |
9,449 |
|
|
$ |
28,983 |
|
|
Interest expense, net |
469 |
|
|
252 |
|
|
762 |
|
|
589 |
|
|||||
Income tax expense from continuing operations |
2,242 |
|
|
9,398 |
|
|
5,680 |
|
|
7,056 |
|
|||||
Depreciation and amortization |
1,944 |
|
|
1,853 |
|
|
3,979 |
|
|
4,497 |
|
|||||
(Gain) loss on disposal group(1) |
— |
|
|
(8,345 |
) |
|
— |
|
|
20,668 |
|
|||||
Stock-based compensation expense |
1,540 |
|
|
1,071 |
|
|
2,765 |
|
|
1,936 |
|
|||||
Legal settlements |
4,665 |
|
|
— |
|
|
4,665 |
|
|
— |
|
|||||
Acquisition costs |
818 |
|
|
— |
|
|
1,030 |
|
|
— |
|
|||||
Adjusted earnings before interest, taxes, depreciation, and amortization (Adjusted EBITDA) from continuing operations |
$ |
7,111 |
|
|
$ |
38,198 |
|
|
$ |
28,330 |
|
|
$ |
63,729 |
|
|
The following table presents a reconciliation of diluted (loss) income per share from continuing operations, the most directly comparable GAAP measure, to Adjusted diluted income per share from continuing operations for the three and six-month periods ended
|
Three-Months Ended |
|
Six-Months Ended |
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
Diluted (loss) income per share from continuing operations |
$ |
(0.15 |
) |
|
$ |
1.05 |
|
|
$ |
0.29 |
|
|
$ |
0.90 |
|
|
(Gain) loss on disposal group, net of tax(1) |
— |
|
|
(0.18 |
) |
|
— |
|
|
0.50 |
|
|||||
Legal settlements |
0.15 |
|
|
— |
|
|
0.14 |
|
|
— |
|
|||||
Acquisition costs |
0.03 |
|
|
— |
|
|
0.03 |
|
|
— |
|
|||||
Adjusted diluted income per share from continuing operations |
$ |
0.03 |
|
|
$ |
0.87 |
|
|
$ |
0.46 |
|
|
$ |
1.40 |
|
|
(1) Gain or loss on disposal group
In accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, for a long-lived assets or disposal group classified as held-for-sale, a loss is recognized for the carrying amount that exceeds the fair market value of the long-lived assets less the cost to sell. The assets and liabilities of a disposal group classified as held-for-sale should be presented separately in the asset and liability sections, respectively, of the balance sheet. The disposal group was structured as a sale of the subsidiary shares and we elected to classify the deferred taxes associated with the individual assets and liabilities as part of the disposal group held-for-sale.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006443/en/
Investor Relations:
646-277-1254
john.mills@ICRinc.com
Media:
360-859-5815
jfread@nautilus.com
The
503-754-7975
ckerns@hoffmn.com
Source:
FAQ
What were Nautilus's net sales for the first half of fiscal 2022?
How many members does the JRNY® platform currently have?
What is the expected operating margin target for Nautilus?
How did Nautilus's Q2 net sales compare to last year?